68Ga ‐PSMA PET/CT for the detection of bone metastases in prostate cancer: a systematic review of the published literature

Conclusion68Ga‐PSMA PET/CT has shown to be a promising technique for use in prostate cancer. 68Ga‐PSMA PET/CT shows more lesions than bone scans, but data on diagnostic performance are very limited and indicate improved diagnostic performance in primary staging but not in mCRPC. Properly designed studies are needed to clarify the diagnostic performance of 68Ga‐PSMA PET/CT as well as its superiority over existing methods before 68Ga‐PSMA PET/CT can be routinely used for bone imaging.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fcpf.12480

Source: Clinical Physiology and Functional Imaging - October 30, 2017 Category: Radiology Authors: Helle D. Zacho, Julie B. Nielsen, Uwe Haberkorn, Louise Stenholt, Lars J. Petersen Tags: Invited Review Source Type: research